Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: A small scale quasi-randomised trial

Trials

Volumn 10, Issue , 2009, Pages

  Yousefi, Bahram ^a   Tadibi, Vahid ^a   Khoei, Ali ^b   Montazeri, Ali ^b  

^a RAZI UNIVERSITY   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ARTAN; LEVODOPA; SELEGILINE; SINMET; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DAILY LIFE ACTIVITY; FEMALE; HEALTH CARE COST; HEALTH STATUS; HUMAN; KINESIOTHERAPY; MALE; PARKINSON DISEASE; QUALITY OF LIFE INDEX; QUASI EXPERIMENTAL STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SOCIAL INTERACTION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE;

ACTIVITIES OF DAILY LIVING; EXERCISE THERAPY; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY OF LIFE;

EID: 70049096034     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-10-67     Document Type: Article

References (33)

1. Giroux ML Parkinson disease: Managing a complex, progressive disease at all stages Cleve Clin J Med 2007, 74:313-4. 317-318, 320-322 10.3949/ ccjm.74.5.313 17506237
2. Greenfield J Bosanquet F The brain-stem lesions in Parkinsonism J Neurol Neurosurg Psychiatry 1953, 16:213-226. 10.1136/jnnp.16.4.213 503142 13109537
3. Hughes AJ Daniel SE Blankson S Lees AJ A clinicopathologic study of 100 cases of Parkinson's disease Arch Neurol 1993, 50:140-148. 8431132
4. Suchowersky O Gronseth G Perlmutter J Reich S Zesiewicz T Weiner WJ Practice parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 2006, 66:968-975. 10.1212/01.wnl.0000215437.80053.d0 16606907
5. Morris ME Movement disorders in people with Parkinson disease: A model for physical therapy Phys Ther 2000, 80:578-597. 10842411
6. Schrag A Jahanshahi M Quinn N How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population Mov Disord 2000, 15:1112-1118. 10.1002/ 1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A 11104193
7. Cutson TM Laub KC Schenkman M Pharmacological and nonpharmacological interventions in the treatment of Parkinson's disease Phys Ther 1995, 75:363-373. 7732080
8. de Goede CJ Keus SH Kwakkel G Wagenaar RC The effects of physical therapy in Parkinson's disease: A research synthesis Arch Phys Med Rehabil 2001, 82:509-515. 10.1053/apmr.2001.22352 11295012
9. Viliani T Pasquetti P Magnolfi S Lunardelli ML Giorgi C Serra P Taiti PG Effects of physical training on straightening-up processes in patients with Parkinson's disease Disabil Rehabil 1999, 21:68-73. 10.1080/ 096382899297990 9990491
10. Baatile J Langbein WE Weaver F Maloney C Jost MB Effect of exercise on perceived quality of life of individuals with Parkinson's disease J Rehabil Res Dev 2000, 37:529-534. 11322151
11. Rodrigues de Paula F Teixeira-Salmela LF Coelho de Morais Faria CD Rocha de Brito P Cardoso F Impact of an exercise program on physical, emotional, and social aspects of quality of life of individuals with Parkinson's disease Mov Disord 2006, 21:1073-1077. 10.1002/mds.20763 16637049
12. Burini D Farabollini B Iacucci S Rimatori C Riccardi G Capecci M Provinciali L Ceravolo MG A randomised controlled cross-over trial of aerobic training versus Qigong in advanced Parkinson's disease Eura Medicophys 2006, 42:231-238. 17039221
13. Crizzle AM Newhouse IJ Is physical exercise beneficial for persons with Parkinson's disease? Clin J Sport Med 2006, 16:422-425. 10.1097/ 01.jsm.0000244612.55550.7d 17016120
14. Ebersbach G Edler D Kaufhold O Wissel J Whole body vibration versus conventional physiotherapy to improve balance and gait in Parkinson's disease Arch Phys Med Rehabil 2008, 89:399-403. 10.1016/ j.apmr.2007.09.031 18295614
15. Goodwin VA Richards SH Taylor RS Taylor AH Campbell JL The effectiveness of exercise interventions foe people with Parkinson's disease: A systematic review and meta-analysis Mov Disord 2008, 15:631-640. 10.1002/ mds.21922
16. Hoehn MM Yahr MD Parkinsonism: Onset, progression, and mortality Neurology 1967, 17:427-442. 6067254
17. Folstein M Folstein S McHugh PR a practical method for grading the cognitive state of patients for the clinician Journal of Psychiatric Research 1975, 12:189-198. 10.1016/0022-3956(75)90026-6 1202204
18. Marinus J Visser M Stiggelbout AM Rabey JM Martínez-Martín P Bonuccelli U Kraus PH van Hilten JJ A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: The SPES/ SCOPA J Neurol Neurosurg Psychiatry 2004, 75:388-395. 10.1136/ jnnp.2003.017509 1738938 14966153
19. de Boer AG Wijker W Speelman JD de Haes JC Quality of life in patients with Parkinson's disease: Development of a questionnaire J Neurol Neurosurg Psychiatry 1996, 61:70-74. 10.1136/jnnp.61.1.70 486462 8676165
20. Gandek B Ware JE Methods for validating and norming translations of health status questionnaires: The IQOLA Project approach. International Quality of Life Assessment J Clin Epidemiol 1998, 51:953-959. 10.1016/ S0895-4356(98)00086-9 9817112
21. Marras C Lang A Changing concepts in Parkinson disease. Moving beyond the decade of the brain Neurology 2008, 70:1996-2003. 10.1212/ 01.wnl.0000312515.52545.51 18490620
22. Keus SH Bloem BR Hendriks EJ Bredero-Cohen AB Munneke M Evidence-based analysis of physical therapy in Parkinson's disease with recommendations for practice and research Mov Disord 2007, 15:451-460. 10.1002/mds.21244
23. Suzukamo Y Ohbu S Kondo T Kohmoto J Fukuhara S Psychological adjustment has a greater effect on health-related quality of life than on severity of disease in Parkinson's disease Mov Disord 2006, 21:761-766. 10.1002/ mds.20817 16511869
24. Muslimovic D Post B Speelman JD Schmand B de Haan RJ Determinants of disability and quality of life in mild to moderate Parkinson disease Neurology 2008, 70:2241-2247. 10.1212/01.wnl.0000313835.33830.80 18519873
25. Mark M Sage J Young Parkinson's Handbook Staten Island, NY: APDA Publications 2000.
26. Boelen M The role of rehabilitative modalities and exercise in Parkinson's disease Dis Mon 2007, 53:259-264. 10.1016/ j.disamonth.2007.02.003 17656187
27. Scandalis TA Bosak A Berliner JC Helman LL Wells MR Resistance training and gait function in patients with Parkinson's disease Am J Phys Med Rehabil 2001, 80:38-43. 10.1097/00002060-200101000-00011 11138953
28. Martinez-Martin P Serrano-Duenas M Forjaz MJ Serrano MS Two questionnaires for Parkinson's disease: Are the PDQ-39 and PDQL equivalent? Qual life Res 2007, 16:1221-1230. 10.1007/s11136-007-9224-2 17534735
29. Hagell P Tornqvist AL Hobart J Testing the Sf-36 in Parkinson's disease. Implications for reporting rating scale data J Neurol 2008, 255:246-254. 10.1007/s00415-008-0708-y 18204806
30. Den Qudsten BL Van Heck GL De Vries J Quality of life and related concepts in Parkinson's disease: A systematic review Mov Disord 2007, 15:1528-1537. 10.1002/mds.21567
31. Hagell P Nygren C The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: Implications for evidence based medicine J Neurol Neurosurg Psychiatry 2007, 78:1191-1198. 10.1136/jnnp.2006.111161 17442762
32. http://www.consort-statement.org/consort-statement/3-12-methods/ 9-allocation-concealment
33. Schulz KF Grimes DA Allocation concealment in randomised trials: defending against deciphering Lancet 2002, 359:614-618. 10.1016/ S0140-6736(02)07750-4 11867132